206 related articles for article (PubMed ID: 25864182)
1. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
3. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
4. Differential Protein Expression in Congenital and Acquired Cholesteatomas.
Shin SH; Huang M; Kim SH; Choi JY
PLoS One; 2015; 10(9):e0137011. PubMed ID: 26335306
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression in acquired cholesteatoma.
Erdoglija M; Milanovic N; Colic M; Jovic M
B-ENT; 2013; 9(3):241-6. PubMed ID: 24273956
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
7. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
[TBL] [Abstract][Full Text] [Related]
8. Integrin expression in middle ear cholesteatoma.
Dallari S; Cavani A; Bergamini G; Girolomoni G
Acta Otolaryngol; 1994 Mar; 114(2):188-92. PubMed ID: 7515549
[TBL] [Abstract][Full Text] [Related]
9. [Congenital cholesteatomas in Japanese--forty from our experience and fifty-five from a survey of the Japanese literature].
Suetake M; Kobayashi T; Sasaki N; Takasaka T; Yuasa R
Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1200-7. PubMed ID: 8914417
[TBL] [Abstract][Full Text] [Related]
10. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
Akimoto R; Pawankar R; Yagi T; Baba S
ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
[TBL] [Abstract][Full Text] [Related]
11. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of significant gene expression changes in congenital and acquired cholesteatoma.
Kaya İ; Avcı ÇB; Şahin FF; Özateş NP; Sezgin B; Kurt CÇ; Bilgen C; Kirazlı T
Mol Biol Rep; 2020 Aug; 47(8):6127-6133. PubMed ID: 32740796
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cadherin/catenin complexes in transformed thyroid epithelial cells: modulation by beta 1 integrin subunit.
Celetti A; Garbi C; Consales C; Cerrato A; Greco D; Mele E; Nitsch L; Grieco M
Eur J Cell Biol; 2000 Sep; 79(9):583-93. PubMed ID: 11043399
[TBL] [Abstract][Full Text] [Related]
14. Positive expression of E-cadherin suppresses cell adhesion to fibronectin via reduction of alpha5beta1 integrin in human breast carcinoma cells.
Wu H; Liang YL; Li Z; Jin J; Zhang W; Duan L; Zha X
J Cancer Res Clin Oncol; 2006 Dec; 132(12):795-803. PubMed ID: 16821070
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
16. Pediatric middle ear cholesteatoma: the comparative study of congenital cholesteatoma and acquired cholesteatoma.
Morita Y; Yamamoto Y; Oshima S; Takahashi K; Takahashi S
Eur Arch Otorhinolaryngol; 2016 May; 273(5):1155-60. PubMed ID: 26044405
[TBL] [Abstract][Full Text] [Related]
17. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of E-cadherin and integrin β-1 in trophoblasts is associated with malignant gestational trophoblastic diseases.
Shu H; Chen H; Yang B; Chang Z; Xiong M; Chen W
Int J Gynecol Cancer; 2013 May; 23(4):749-54. PubMed ID: 23455756
[TBL] [Abstract][Full Text] [Related]
19. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
